WatchRecovering

ACADACADIA Pharmaceuticals Inc.

Healthcare · Biotechnology · mid-cap ($3.6B)
-23.7%
from rolling 252-day high of $28.35 set 2025-12-23 · 156d ago
Current
$21.63
Decline depth
-23.7%
Decline σ
4.2σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$ACAD landed on the list 2026-03-03, down 20.6% from its 52-week high that day — now down -23.7%.

That's 4.4 percentage points deeper than the day it joined. It bottomed 28.3% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-03 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

ACAD qualifies for the Watch on decline depth.

Decline depth
-23.7%
From rolling 252-day high of $28.35, 156d ago. Past the 20% Watch threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.2σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.26% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about ACAD.

ACAD qualifies for the Watch on decline depth — down -23.7% from its rolling 252-day high.

Cross-confirmation: decline sigma also reads 4.2σ over 20 bars.

Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.

Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether ACAD's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.

Upstream TFC read: moderate alignment, current phase daily. Last bar types — daily 3 (green), weekly 2U (green), monthly 3 (red).

Earnings on file: 2026-02-25. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $13.40 55.1% of range 52W high $28.35

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
47 Amber
58 Watch
-36.0% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about ACAD

What people ask.

Why is ACAD on Broken Stocks?

ACAD qualifies for the Watch on decline depth. It is down -23.7% from its rolling 252-day high of $28.35, set on 2025-12-23 — 156d ago. It additionally carries a Recovering badge — see below.

What does the Recovering badge mean for ACAD?

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — ACAD is still Watch because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

Is ACAD a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. ACAD is down -23.7% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is ACAD a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ACAD trading inside its 52-week range?

At $21.63, ACAD sits 55.1% of the way from its 52-week low ($13.40) to its 52-week high ($28.35). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ACAD been declining?

The current 23.7% decline accrued over 156d, which annualizes to roughly -55.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ACAD compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 47 Amber, 58 Watch, with 107 showing recovering structural signals. Median sector decline is -36.0% — ACAD's decline is shallower than the sector median.

Does ACAD's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-25) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.